As of June 2, 2025, mcePharma has been officially acquired by Brenntag, the global market leader in chemical and ingredient distribution.
This strategic partnership will allow to expand capabilities, global reach and portfolio of innovative solutions, creating a unique position to serve fast growing demand in Biopharma market with GMP value added services.
Additional investments will expand capabilities of GMP blending and down-packing to integrate GMP biobuffers and liquid blending in order to meet the growing demand of customers and supply partners.
Brenntag’s extensive network, resources and commitment to excellence and innovation perfectly align with mcePharma’s dedication to delivering high-quality products and exceptional customer service.